|
KMID : 1001020090070010006
|
|
Journal of Urologic Oncology
2009 Volume.7 No. 1 p.6 ~ p.11
|
|
|
Update of Intravesical Therapy on Non-Muscle Invasive Bladder Cancer
|
|
Rhew Hyun-Yul
Kim Taek-Sang
|
|
|
Abstract
|
|
|
|
For non-muscle invasive bladder cancer, intravesical pharmacotherapy after transurethral resection of bladder tumor is widely used for reducing recurrence and progression. All patients with non-muscle invasive bladder cancer, an immediate instillation after transurethral resection of bladder tumor is needed for reduce recurrence. For intermediate and high risk non-muscle invasive bladder cancer patients, adjuvant intravesical chemotherapy or immunotherapy is advised, especially, intravesical BCG instillation is proven to reduce progression. After recurrence or progression, there are many strategies such as second-line intravesical chemotherapy, immunotherapy, device-assisted therapies, or radical cystectomy. We reviewed and summarized the current status of intravesical chemotherapy and immunotherapy.
|
|
|
KEYWORD
|
|
|
Bladder cancer, Intravesical chemotherapy, Immunotherapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|